semaglutide cancer study Can obesity meds also reduce risk? A retrospective of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked For years, researchers have known

Continue reading to learn more about GLP-1 drugs and their potential benefits and risks for people currently living with breast cancer and for breast cancer survivors

Angelova P

We publish certificates of analysis (COAs) for transparency and accountability

It can also be used along with other diabetes medications, like metformin, if needed

Separate head-to-head obesity trials published in peer-reviewed journals reported greater average reductions for tirzepatide than semaglutide under controlled study conditions, though individual response, tolerability, and clinical suitability varied across participants

(ADD-ONS available upon request during Physician consultation) Contains: Fluids, Electrolytes, B-Complex or B-12 (Optional) Nicotinamide adenine dinucleotide is an essential cofactor in the body important to many body functions